Michael Feher
-
- Diabetes Treatment and Management 36
- Diabetes Management and Research 31
- Diabetes, Cardiovascular Risks, and Lipoproteins 19
- Diabetes Management and Education 10
- Nephrology top 2%
- Clinical Biochemistry top 5%
- Surgery top 5%
- Lipoproteins and Cardiovascular Health 21
-
- Metabolism, Diabetes, and Cancer 14
-
- Cardiac Imaging and Diagnostics 10
-
- Chronic Disease Management Strategies 7
- Co-authors
- Andrew ZambaniniR. S. ElkelesRoger NewsonAnthony S. WierzbickiW. RichmondSimon de LusignanNeil MunroF B Gibberd
- Partner nations
- United KingdomItalyNetherlands
In The Last Decade
Michael Feher
130 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 137
- Endocrinology, Diabetes and Metabolism 1.1k
- Nephrology 217
- Clinical Biochemistry 129
- Cardiology and Cardiovascular Medicine 410
- Surgery 707
Countries citing papers authored by Michael Feher
This map shows the geographic impact of Michael Feher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Feher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Feher more than expected).
Fields of papers citing papers by Michael Feher
This network shows the impact of papers produced by Michael Feher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Feher. The network helps show where Michael Feher may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Feher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 16 | |
| 3 | 2023 | 10 | |
| 4 | 2022 | 6 | |
| 5 | 2022 | 16 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 0 | |
| 8 | 2022 | 6 | |
| 9 | 2021 | 3 | |
| 10 | 2020 | 0 | |
| 11 | 2019 | 1 | |
| 12 | 2017 | 41 | |
| 13 | 2016 | 21 | |
| 14 | 2014 | 13 | |
| 15 | Anxiety associated with self-monitoring of capillary blood glucose : learning from practice | 2014 | 1 |
| 16 | 2013 | 20 | |
| 17 | 2004 | 28 | |
| 18 | 2000 | 2 | |
| 19 | Hypertension in diabetes mellitus | 1993 | 1 |
| 20 | 1989 | 3 |
About Michael Feher
Michael Feher is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Family Practice, Surgery and Cardiology and Cardiovascular Medicine, having authored 137 papers that have together received 2.5k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (36 papers), Diabetes Management and Research (31 papers), Lipoproteins and Cardiovascular Health (21 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers), Metabolism, Diabetes, and Cancer (14 papers), Diabetes Management and Education (10 papers), Cardiac Imaging and Diagnostics (10 papers) and Chronic Disease Management Strategies (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Nephrology (217 citations), Clinical Biochemistry (129 citations), Cardiology and Cardiovascular Medicine (410 citations) and Surgery (707 citations). Michael Feher has collaborated with scholars based in United Kingdom, Italy and Netherlands. Frequent co-authors include Andrew Zambanini, R. S. Elkeles, Roger Newson, Anthony S. Wierzbicki, W. Richmond, Simon de Lusignan, Neil Munro, F B Gibberd, Ian F. Godsland and H Brain. Their work appears in journals such as Diabetic Medicine, Diabetes Therapy, Atherosclerosis, Diabetes Obesity and Metabolism and Diabetes Research and Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.